International Clinical Trial: A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GS-3107 Coadministered with Encequidar in Healthy Participants

Geneva, May 7 -- International Clinical Trials Registry received information related to the study (ACTRN12626000554369) titled 'A Phase 1 Study to Evaluate the Safety, Tolerability and Pharmacokinetics of GS-3107 Coadministered with Encequidar in Healthy Participants' on May 1.

Study Type: Interventional

Study Design: Purpose: Treatment Allocation: Non-randomised trial Type of endpoint: Safety

Primary Sponsor: Gilead Sciences Inc

Condition: HIV-1 Infection HIV-1 Infection Infection - Acquired immune deficiency syndrome (AIDS / HIV)

Intervention: The study will proceed with up to 8 cohorts in 4 parts, governed by a review of safety and available PK data and applicable stopping rules. Each cohort is open label with no arms within ea...